mounjaro es semaglutide Tirzepatide vs for Weight Loss Treatment Mounjaro Weight Loss Injections in

The bottom line

The general adult weight-management indication includes patients with an initial: BMI of 30 kg/m2 or above, or BMI from 27 kg/m2 to below 30 kg/m2 with at least one weight-related health condition Relevant conditions may include: high blood pressure abnormal cholesterol levels obstructive sleep apnoea cardiovascular disease prediabetes type 2 diabetes Meeting these general criteria does not guarantee that treatment will be prescribed

Although GLP-1 medications have transformed obesity treatment, there remains a significant need for rigorous data examining how these therapies affect fertility and reproductive function in this population. The RESTORE study is currently evaluating semaglutide treatment in girls and women with PMOS and obesity, with the overarching goal of determining whether weight loss and metabolic improvements can restore ovulation and improve reproductive outcomes

At 2.5 mg/mL, 40 units delivers 1.0 mg, a moderate mid-range dose

While patients will not see results from semaglutide drops overnight, they will likely see the impact in as little as four to eight weeks

Up to 76% off